US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist

41.650
+1.000+2.46%

Close Nov 21 16:00 ET

41.650
0.0000.00%

Post 20:01 ET

2.48BMarket Cap15.20P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.70%-27.86M

1,123.79%268.62M

20.14%-27.43M

35.05%-70.24M

153.61%16.96M

-5.60%-26.61M

-92.43%-26.24M

8.81%-34.35M

-0.25%-108.14M

-17.43%-31.64M

Net income from continuing operations

2.62%-33.21M

20.40%-30.62M

714.80%207.34M

38.02%-78.96M

179.94%27.34M

-9.20%-34.11M

6.28%-38.46M

-61.13%-33.73M

-1.47%-127.39M

7.35%-34.19M

Depreciation and amortization

-21.77%647K

8.65%892K

-1.44%820K

-1.69%3.31M

-0.95%832K

-3.05%827K

-2.61%821K

-0.12%832K

21.41%3.37M

2.56%840K

Other non cash items

----

--194K

--0

--194K

----

Change In working capital

-389.32%-2.63M

7,144.00%291.06M

-2,950.34%-243.33M

-151.24%-19.51M

-471.73%-16.46M

232.94%908K

-79.56%4.02M

66.57%-7.98M

-134.34%-7.77M

-179.62%-2.88M

-Change in receivables

10.26%43K

2,499,900.00%300M

-707,321.95%-290.04M

-335.50%-9.99M

-12,295.12%-10M

-98.52%39K

-99.95%12K

99.83%-41K

563.61%4.24M

-45.70%82K

-Change in prepaid assets

-84.90%-1.16M

-241.15%-2.01M

-216.26%-915K

-53.30%1.75M

-94.88%171K

-194.16%-629K

192.83%1.42M

-38.47%787K

216.33%3.75M

661.51%3.34M

-Change in payables and accrued expense

52.17%3.33M

-168.55%-2.24M

140.76%3.28M

25.82%-8.53M

-5.47%-5.94M

166.05%2.19M

231.21%3.26M

-11,398.57%-8.05M

-172.45%-11.5M

-204.65%-5.63M

-Change in other current liabilities

76.05%-166K

23.09%-523K

-3.26%-696K

-3.08%-2.74M

-3.11%-696K

-3.28%-693K

-2.87%-680K

-3.06%-674K

-22.63%-2.66M

0.30%-675K

-Change in other working capital

---4.68M

---4.17M

--45.05M

----

87.57%-1.6M

--0

Cash from discontinued investing activities

Operating cash flow

-4.70%-27.86M

1,123.79%268.62M

20.14%-27.43M

35.05%-70.24M

153.61%16.96M

-5.60%-26.61M

-92.43%-26.24M

8.81%-34.35M

-0.25%-108.14M

-17.43%-31.64M

Investing cash flow

Cash flow from continuing investing activities

-1,439.27%-208.71M

-442.05%-88.12M

-38.21%6.07M

-142.92%-39.26M

-1,657.48%-61.29M

-123.67%-13.56M

-25.83%25.76M

319.53%9.83M

676.72%91.47M

-85.88%3.94M

Net PPE purchase and sale

-91.83%-775K

84.09%-28K

-2,320.00%-242K

23.40%-609K

72.86%-19K

-149.38%-404K

39.31%-176K

96.34%-10K

27.79%-795K

64.29%-70K

Net investment purchase and sale

-1,480.65%-207.94M

-439.62%-88.09M

-35.82%6.31M

-141.89%-38.65M

-1,629.79%-61.27M

-122.90%-13.16M

-25.94%25.94M

334.02%9.84M

725.13%92.26M

-85.73%4.01M

Cash from discontinued investing activities

Investing cash flow

-1,439.27%-208.71M

-442.05%-88.12M

-38.21%6.07M

-142.92%-39.26M

-1,657.48%-61.29M

-123.67%-13.56M

-25.83%25.76M

319.53%9.83M

676.72%91.47M

-85.88%3.94M

Financing cash flow

Cash flow from continuing financing activities

-65.88%12.05M

-97.62%2.57M

-72.80%7.2M

804.96%170.48M

-4.70%527K

5,093.38%35.32M

15,807.65%108.17M

56.35%26.46M

-85.50%18.84M

-74.55%553K

Net common stock issuance

--0

807.72%132.1M

--8K

---78K

--107.87M

66.99%24.3M

-88.25%14.55M

--0

Proceeds from stock option exercised by employees

-65.95%12.05M

164.34%2.57M

244.94%7.8M

780.08%39.15M

-6.15%519K

5,089.59%35.39M

48.55%973K

-11.61%2.26M

-29.21%4.45M

-76.36%553K

Net other financing activities

--0

-500.00%-600K

-371.78%-769K

--0

-2,776.00%-669K

46.24%-100K

13.76%-163K

--0

Cash from discontinued financing activities

Financing cash flow

-65.88%12.05M

-97.62%2.57M

-72.80%7.2M

804.96%170.48M

-4.70%527K

5,093.38%35.32M

15,807.65%108.17M

56.35%26.46M

-85.50%18.84M

-74.55%553K

Net cash flow

Beginning cash position

51.04%355.87M

35.09%172.79M

48.41%186.95M

1.68%125.97M

50.78%230.75M

95.59%235.61M

29.59%127.91M

1.68%125.97M

5.15%123.89M

26.72%153.04M

Current changes in cash

-4,524.55%-224.52M

69.99%183.08M

-829.09%-14.16M

2,711.57%60.98M

-61.34%-43.8M

-114.82%-4.86M

394.49%107.7M

107.70%1.94M

-65.00%2.17M

-975.43%-27.15M

Effect of exchange rate changes

----

--0

----

28.57%-90K

240.91%75K

End cash Position

-43.08%131.35M

51.04%355.87M

35.09%172.79M

48.41%186.95M

50.78%230.75M

95.59%235.61M

29.59%127.91M

1.68%125.97M

Free cash flow

-6.01%-28.64M

1,116.86%268.59M

19.46%-27.67M

34.96%-70.85M

153.43%16.94M

-6.51%-27.02M

-89.69%-26.41M

9.44%-34.36M

0.03%-108.93M

-16.84%-31.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.70%-27.86M	1,123.79%268.62M	20.14%-27.43M	35.05%-70.24M	153.61%16.96M	-5.60%-26.61M	-92.43%-26.24M	8.81%-34.35M	-0.25%-108.14M	-17.43%-31.64M
Net income from continuing operations	2.62%-33.21M	20.40%-30.62M	714.80%207.34M	38.02%-78.96M	179.94%27.34M	-9.20%-34.11M	6.28%-38.46M	-61.13%-33.73M	-1.47%-127.39M	7.35%-34.19M
Depreciation and amortization	-21.77%647K	8.65%892K	-1.44%820K	-1.69%3.31M	-0.95%832K	-3.05%827K	-2.61%821K	-0.12%832K	21.41%3.37M	2.56%840K
Other non cash items	----	----	----	--194K	--0	--0	--0	--194K	----	----
Change In working capital	-389.32%-2.63M	7,144.00%291.06M	-2,950.34%-243.33M	-151.24%-19.51M	-471.73%-16.46M	232.94%908K	-79.56%4.02M	66.57%-7.98M	-134.34%-7.77M	-179.62%-2.88M
-Change in receivables	10.26%43K	2,499,900.00%300M	-707,321.95%-290.04M	-335.50%-9.99M	-12,295.12%-10M	-98.52%39K	-99.95%12K	99.83%-41K	563.61%4.24M	-45.70%82K
-Change in prepaid assets	-84.90%-1.16M	-241.15%-2.01M	-216.26%-915K	-53.30%1.75M	-94.88%171K	-194.16%-629K	192.83%1.42M	-38.47%787K	216.33%3.75M	661.51%3.34M
-Change in payables and accrued expense	52.17%3.33M	-168.55%-2.24M	140.76%3.28M	25.82%-8.53M	-5.47%-5.94M	166.05%2.19M	231.21%3.26M	-11,398.57%-8.05M	-172.45%-11.5M	-204.65%-5.63M
-Change in other current liabilities	76.05%-166K	23.09%-523K	-3.26%-696K	-3.08%-2.74M	-3.11%-696K	-3.28%-693K	-2.87%-680K	-3.06%-674K	-22.63%-2.66M	0.30%-675K
-Change in other working capital	---4.68M	---4.17M	--45.05M	----	----	----	----	----	87.57%-1.6M	--0
Cash from discontinued investing activities
Operating cash flow	-4.70%-27.86M	1,123.79%268.62M	20.14%-27.43M	35.05%-70.24M	153.61%16.96M	-5.60%-26.61M	-92.43%-26.24M	8.81%-34.35M	-0.25%-108.14M	-17.43%-31.64M
Investing cash flow
Cash flow from continuing investing activities	-1,439.27%-208.71M	-442.05%-88.12M	-38.21%6.07M	-142.92%-39.26M	-1,657.48%-61.29M	-123.67%-13.56M	-25.83%25.76M	319.53%9.83M	676.72%91.47M	-85.88%3.94M
Net PPE purchase and sale	-91.83%-775K	84.09%-28K	-2,320.00%-242K	23.40%-609K	72.86%-19K	-149.38%-404K	39.31%-176K	96.34%-10K	27.79%-795K	64.29%-70K
Net investment purchase and sale	-1,480.65%-207.94M	-439.62%-88.09M	-35.82%6.31M	-141.89%-38.65M	-1,629.79%-61.27M	-122.90%-13.16M	-25.94%25.94M	334.02%9.84M	725.13%92.26M	-85.73%4.01M
Cash from discontinued investing activities
Investing cash flow	-1,439.27%-208.71M	-442.05%-88.12M	-38.21%6.07M	-142.92%-39.26M	-1,657.48%-61.29M	-123.67%-13.56M	-25.83%25.76M	319.53%9.83M	676.72%91.47M	-85.88%3.94M
Financing cash flow
Cash flow from continuing financing activities	-65.88%12.05M	-97.62%2.57M	-72.80%7.2M	804.96%170.48M	-4.70%527K	5,093.38%35.32M	15,807.65%108.17M	56.35%26.46M	-85.50%18.84M	-74.55%553K
Net common stock issuance	--0	--0	--0	807.72%132.1M	--8K	---78K	--107.87M	66.99%24.3M	-88.25%14.55M	--0
Proceeds from stock option exercised by employees	-65.95%12.05M	164.34%2.57M	244.94%7.8M	780.08%39.15M	-6.15%519K	5,089.59%35.39M	48.55%973K	-11.61%2.26M	-29.21%4.45M	-76.36%553K
Net other financing activities	--0	--0	-500.00%-600K	-371.78%-769K	--0	--0	-2,776.00%-669K	46.24%-100K	13.76%-163K	--0
Cash from discontinued financing activities
Financing cash flow	-65.88%12.05M	-97.62%2.57M	-72.80%7.2M	804.96%170.48M	-4.70%527K	5,093.38%35.32M	15,807.65%108.17M	56.35%26.46M	-85.50%18.84M	-74.55%553K
Net cash flow
Beginning cash position	51.04%355.87M	35.09%172.79M	48.41%186.95M	1.68%125.97M	50.78%230.75M	95.59%235.61M	29.59%127.91M	1.68%125.97M	5.15%123.89M	26.72%153.04M
Current changes in cash	-4,524.55%-224.52M	69.99%183.08M	-829.09%-14.16M	2,711.57%60.98M	-61.34%-43.8M	-114.82%-4.86M	394.49%107.7M	107.70%1.94M	-65.00%2.17M	-975.43%-27.15M
Effect of exchange rate changes	----	----	----	--0	----	----	----	----	28.57%-90K	240.91%75K
End cash Position	-43.08%131.35M	51.04%355.87M	35.09%172.79M	48.41%186.95M	48.41%186.95M	50.78%230.75M	95.59%235.61M	29.59%127.91M	1.68%125.97M	1.68%125.97M
Free cash flow	-6.01%-28.64M	1,116.86%268.59M	19.46%-27.67M	34.96%-70.85M	153.43%16.94M	-6.51%-27.02M	-89.69%-26.41M	9.44%-34.36M	0.03%-108.93M	-16.84%-31.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data